Acertis Pharma Licenses Commercial Rights to Licart from IBSA
21 Jan 2026 //
BUSINESSWIRE
Acertis Pharma Licenses Commercial Rights to Licart from IBSA
07 Jan 2026 //
BUSINESSWIRE
Yaral Pharma Launches Diclofenac Epolamine Topical System 1.3%
03 Jan 2023 //
BUSINESSWIRE
Altasciences Chosen by Virpax Pharma to Conduct Study of Epoladerm
21 Jan 2022 //
BUSINESSWIRE
Virpax Pharmaceuticals Reports Pre-IND Guidance From FDA for DSF100
12 Sep 2018 //
BUSINESSWIRE

Market Place
Sourcing Support